• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/24/14

    • 30-Day SEC Yield1

      -0.13%
    • Total Net Assets

      $586.4M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 10/24/14

    • % of Net Assets
    • Stocks

      99.89
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.11
  • Download All HoldingsAll Holdings (%)as of 10/24/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    817,858
    90,545,05915.44
    Amgen Inc
    AMGN US
    453,275
    66,749,27711.38
    Celgene Corp
    CELG US
    566,142
    58,448,5009.97
    Biogen Idec Inc
    BIIB US
    142,792
    45,931,9037.83
    Alexion Pharmaceuticals Inc
    ALXN US
    169,224
    32,201,6355.49
    Vertex Pharmaceuticals Inc
    VRTX US
    266,294
    29,268,3744.99
    Regeneron Pharmaceuticals Inc
    REGN US
    71,202
    28,658,8054.89
    Illumina Inc
    ILMN US
    141,621
    26,783,3644.57
    Biomarin Pharmaceutical Inc
    BMRN US
    280,183
    22,703,2283.87
    Pharmacyclics Inc
    PCYC US
    162,648
    20,116,3053.43
    Medivation Inc
    MDVN US
    194,055
    19,768,3833.37
    Incyte Corp Ltd
    INCY US
    351,579
    19,361,4563.30
    Qiagen Nv
    QGEN US
    765,714
    17,488,9082.98
    United Therapeutics Corp
    UTHR US
    110,797
    14,664,5372.50
    Puma Biotechnology Inc
    PBYI US
    51,845
    12,497,2372.13
    Cubist Pharmaceuticals Inc
    CBST US
    169,196
    12,001,0722.05
    Isis Pharmaceuticals Inc
    ISIS US
    224,225
    10,090,1251.72
    Covance Inc
    CVD US
    122,161
    9,859,6141.68
    Alkermes Plc
    ALKS US
    213,637
    9,808,0751.67
    Intercept Pharmaceuticals Inc
    ICPT US
    38,077
    9,048,9991.54
    Charles River Laboratories Internationa
    CRL US
    123,087
    7,839,4111.34
    Cepheid Inc
    CPHD US
    133,711
    6,696,2471.14
    Nps Pharmaceuticals Inc
    NPSP US
    238,072
    6,411,2791.09
    Myriad Genetics Inc
    MYGN US
    127,972
    4,729,8450.81
    Seattle Genetics Inc
    SGEN US
    113,032
    4,063,5000.69
    Other/Cash
    631,2630.11
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.